Hemolytic disease due to fetomaternal alloimmunization

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

4 events
Oct 2025Risk Factors and Clinical Outcomes of Neonatal Anemia in NICU

Assiut University

TrialNOT YET RECRUITING
Feb 2025A Study on Hemolytic Disease of the Fetus and Newborn (HDFN) Through Global Registry

Janssen Research & Development, LLC

TrialRECRUITING
Jul 2024Cord Blood S100B Protein Levels in Neonates Following Intrauterine Transfusions for HDFN-Associated Fetal Anemia

Institute of Mother and Child, Warsaw, Poland

TrialRECRUITING
Dec 2023A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)

Janssen Research & Development, LLC — PHASE3

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Hemolytic disease due to fetomaternal alloimmunization.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

PHYTONADIONE PHYTONADIONE

(PHYTONADIONE)Orphan drugstandard

Dr.Reddy's Laboratories Inc

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

3 active trials
1Phase 3
2Unknown
3Total recruiting
Search clinical trials for Hemolytic disease due to fetomaternal alloimmunization

Recent News & Research

No recent news articles indexed yet for Hemolytic disease due to fetomaternal alloimmunization.
Search PubMed for Hemolytic disease due to fetomaternal alloimmunization

Browse all Hemolytic disease due to fetomaternal alloimmunization news →

Specialist Network

Top 1 by expertise

View all Hemolytic disease due to fetomaternal alloimmunization specialists →

Quick Actions